CI vs SRPT · P/E 2.4, rev $274.90B vs rev $1.90B
Cigna Corp (CI) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Cigna Corp (CI) is a healthcare plans company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported CI revenue for 2025-12-31 was $274.90B. Net income was $5.96B. Revenue was up 11.2% from 2024-12-31 to 2025-12-31. CI currently screens at market cap $71.62B and trailing P/E 2.4.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
CI currently screens at market cap $71.62B and trailing P/E 2.4. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the CI and SRPT stock pages for the full models.
Not investment advice.